Shi Yan1, Chunsheng Jin2, Iain B H Wilson1, Katharina Paschinger1. 1. Department für Chemie, Universität für Bodenkultur , 1190 Wien, Austria. 2. Institutionen för Biomedicin, Göteborgs Universitet , 405 30 Göteborg, Sweden.
Abstract
Recent studies have shown a remarkable degree of plasticity in the N-glycome of the model nematode Caenorhabditis elegans; ablation of glycosylation-relevant genes can result in radically altered N-glycan profiles despite only minor biological phenotypic effects. Up to four fucose residues and five different linkages of fucose are known on the N-glycans of C. elegans. Due to the complexity in the wild type, we established three mutant strains defective in two core fucosyltransferases each (fut-1;fut-6, fut-1;fut-8, and fut-6;fut-8). Enzymatically released N-glycans were subject to HPLC and MALDI-TOF MS/MS, in combination with various treatments, to verify structural details. The N-glycome of the fut-1;fut-6 mutant was the most complex of the three double-mutant strains due to the extension of the core α1,6-fucose as well as the presence of fucose on the bisecting galactose. In contrast, maximally two fucoses were found on N-glycans of the fut-1;fut-8 and fut-6;fut-8 strains. The different locations and capping of fucose meant that up to 13 isomeric structures, many highly galactosylated, were determined for some single masses. These data not only show the high variability of the N-glycomic capacity of a "simple" nematode but also exemplify the need for multiple approaches to reveal individual glycan structures within complex invertebrate glycomes.
Recent studies have shown a remarkable degree of plasticity in the N-glycome of the model nematode Caenorhabditis elegans; ablation of glycosylation-relevant genes can result in radically altered N-glycan profiles despite only minor biological phenotypic effects. Up to four fucose residues and five different linkages of fucose are known on the N-glycans of C. elegans. Due to the complexity in the wild type, we established three mutant strains defective in two core fucosyltransferases each (fut-1;fut-6, fut-1;fut-8, and fut-6;fut-8). Enzymatically released N-glycans were subject to HPLC and MALDI-TOF MS/MS, in combination with various treatments, to verify structural details. The N-glycome of the fut-1;fut-6 mutant was the most complex of the three double-mutant strains due to the extension of the core α1,6-fucose as well as the presence of fucose on the bisecting galactose. In contrast, maximally two fucoses were found on N-glycans of the fut-1;fut-8 and fut-6;fut-8 strains. The different locations and capping of fucose meant that up to 13 isomeric structures, many highly galactosylated, were determined for some single masses. These data not only show the high variability of the N-glycomic capacity of a "simple" nematode but also exemplify the need for multiple approaches to reveal individual glycan structures within complex invertebrate glycomes.
It
is probably still a widely held opinion that “lower”
organisms only have “simple” glycomes and that glycomic
profiling is sufficient for analyzing their protein-linked oligosaccharides;
however, data obtained over the years indicate a wide range of variability
and complexity of the N-linked glycans from protozoan and invertebrate
species.[1] This applies not only to many
parasitic species or intermediate hosts for pathogens but also to
model organisms such as Dictyostelium, Drosophila, and Caenorhabditis.[2,3] For instance,
the most complicated N-glycans in Dictyostelium contain
core α1,3-fucose, inter- and bisecting GlcNAc, sulfate, and
methylphosphate residues;[4] in addition
to the pauci- and oligomannosidic N-glycans typical of invertebrates, Drosophila expresses a range of sialylated, glucuronylated,
and sulfated structures,[5,6] while in Caenorhabditis structures with up to four fucose residues (in part capped with
hexose residues) as well as methyl and phosphorylcholine modifications
have been described.[7−11] Although extended nonreducing modifications, typical of vertebrates,
are rare in insects and nematodes, up to three antennae can be present
on N-glycans in such species.The ability to manipulate glycosylation
pathways in these model
species by isolating or generating mutants enables the investigation
not only of glycan function but also of the plasticity of the biosynthetic
potential. The latter effect is probably most obvious with Caenorhabditis, for which the largest range of N-glycans
has been detected for any invertebrate model,[11] also when considering the structures present in glycosylation mutants
as exemplified by a triple knockout of all N-acetylglucosaminyltransferase
I isoforms,[12] knockouts of a putative S-adenosylmethionine transporter,[13] of GDP-fucose metabolism,[14] and of a
conserved oligomeric Golgi (COG) complex subunit[15] as well as single and multiple deletion strains of Golgi
glycosidases[16−18] and fucosyltransferases.[19,20] Many of these mutations had a major impact on the N-glycome of C. elegans but are normally associated with no obvious laboratory
phenotype other than often altered sensitivity to toxic lectins or
to pathogenic bacteria.[21,22]The complex web
of glycosyltransferase specificities and “GO-NOGO”
biosynthetic signals generated in the absence of certain glycan-modifying
enzymes in the Golgi result in a large and, in part, unpredictable
range of final N-glycan structures. Despite some progress, many of
the biosynthetic routes generating this glycan variability are still
unclear, as is the exact nature of some of the linkages. In our own
laboratory, we have focused on deciphering the fucosylation pattern
of C. elegans N-glycans. In total, five different
positions for fucosylation have been found on C. elegans N-glycans (with maximally four per structure): core α1,3-
and core α1,6-fucose on the reducing (proximal) N-acetylglucosamine, α1,3-fucose on the second (distal) core
GlcNAc, α1,2-fucose capping of the core Galβ1,4Fucα1,6
epitope, and α1,2-fucose on the bisecting β1,4-linked
galactose substituting the core β-mannose residue.[10,18,20] Whereas maximally three, rather
than four, fucose residues were observed for N-glycans from the Golgi
mannosidase II (aman-2) and fucosyltransferase (fut-1 and fut-6) mutants,[17,19] more radical reductions in the degree of N-glycan fucosylation were
seen for the Golgi double hexosaminidase (hex-2;hex-3) and triple fucosyltransferase (fut-1;fut-6;fut-8) deletion strains.[18,20] The reduced N-glycome complexity
of the latter two strains enabled us to define unusual modifications
such as Galα1,2Fuc on the distal core GlcNAc and “bisecting”
Fucα1,2Gal on the core β-mannose. Nevertheless, because
of the published data there are at least two α1,2-fucosyltransferases,
two β1,4-galactosyltransferases, and two α-galactosyltransferases
as well as multiple methyltransferases to be discovered that are responsible
for the formation of the highly fucosylated core structures.Indeed the definition of individual N-glycan structures is complicated
in C. elegans by the multiplicity of locations for
fucosylation as well as capping of residues by galactose, methyl,
or phosphorylcholine moieties. This results in a large number of isomeric
structures that must be adequately separated and distinguished as
part of any glycomic workflow; thereby, sequential differential release
with PNGase F, followed by PNGase A (only the latter cleaving core
α1,3-fucosylated N-glycans[23]) as
well as RP-HPLC and 2D-HPLC in combination with mass spectrometry
and chemical or enzymatic treatments is required.While the
N-glycans of the triple fucosyltransferase mutant lacked
all core fucose residues and possessed maximally one fucose residue
on the bisecting galactose,[20] initial mass
spectrometric screening of the PNGase F-released N-glycans of three
double fucosyltransferase mutants (fut-1;fut-6, fut-1;fut-8, and fut-6;fut-8) indicated
that significant amounts of difucosylated oligosaccharides were still
apparent in the first two.[24] In the present
study, based on the lessons learnt from the analysis of the triple
fucosyltransferase mutant[20] as well as
clues from other studies,[8,10] we have performed an
in-depth N-glycomic analysis of the three double fucosyltransferase
mutants that vary in terms of which fucosylation events can still
take place while still being less complex than the wild type. Our
analyses reveal an unprecedented isomeric complexity in the glycomic
potential of the nematode and so will be valuable in a final definition
of the structures of the N-linked oligosaccharides of the wild-type
as well as revealing aspects of the biosynthetic pathways in this
model organism.
Experimental Procedures
Preparation of C. elegans Double Mutants
Wild-type C.
elegans (N2) and single mutants fut-1 (ok892, II), fut-6 (ok475, II) and fut-8 (ok2558, V) were
obtained from the Caenorhabditis Genetics
Centre (CGC), University of Minnesota, USA. All C. elegans strains were cultured under standard conditions at 20 °C.[25] Analogously to the procedure for the fut-1;fut-6 double mutant,[26] also fut-1;fut-8 and fut-6;fut-8 strains were
prepared. PCR primers were designed to target the mutant alleles.
Multiplex PCR screening was employed to simplify this process when
handling a large number of DNA samples for screening. Primers used
are 5′-CTAAATTGGCATCCACAACCT-3′,
5′-GCCATTTATTAACAGTTCTCAT-3′
and 5′-CCGGAGTAATTAGACCTGC-3′
for probing fut-1; 5′-GAATGCCACCATGCAACAT-3′,
5′-GAATTACCCATGATACTAGAT-3′
and 5′-GCCCCAAATATCAATCTGC-3′
for probing fut-6; and 5′-TCAGTCTTCGCCAATCAT-3′,
5′-TAAAAGGAGTGTCCATTG-3′
and 5′-AATTACCGCATTTGCTAC-3′
for probing fut-8. Expected and observed amplicon
sizes are shown in Supplementary Figure S-1. Genomic DNAs from wild-type worm and single mutants were combined
to prepare artificial heterozygous genomes as PCR reference sample;
for example, a mixture of N2 and fut-1 genomic DNA
was used to aid the examination of the fut-1;fut-6 genotype. The 100 bp DNA GeneRuler ladder (Thermo Fisher Scientific)
was used to estimate the sizes of the DNA amplicons.
N-Glycan Preparation
and MALDI TOF MS Analysis
C. elegans was
grown in liquid culture with E. coli OP50 in standard
S complete medium, and mixed stages were harvested
after cultivation at room temperature (20 °C) for 4–6
days and purified by sucrose density centrifugation. After proteolysis
with pepsin, N-glycans were released from worm peptides using peptide:N-glycosidase
F (Roche) as previously described,[27] with
a subsequent digestion of remaining glycopeptides using peptide:N-glycosidase
A (Roche). The N-glycomes of the mutants were profiled by MALDI-TOF
MS (Autoflex Speed, Bruker Daltonics, Germany) in positive ion mode
using FlexControl 3.4 software. Free glycans were labeled with 2-aminopyridine
prior to fractionation by reversed-phase HPLC (RP-HPLC), also in combination
with either normal phase or hydrophilic interaction columns (see later).
All HPLC peaks were collected and examined by MALDI-TOF MS using 6-aza-2-thiothymine
(ATT) as matrix; MS/MS to confirm the composition of all proposed
structures was performed by laser-induced dissociation (precursor
ion selector was generally set to ±0.6%). The detector voltage
was generally set at 1977 V for MS and 2133 V for MS/MS; 1000–3000
shots from different regions of the sample spots were summed. Spectra
were processed with the manufacturer’s software (Bruker Flexanalysis
3.3.80) using the SNAP algorithm with a signal/noise threshold of
6 for MS (unsmoothed) and 3 for MS/MS (four-times smoothed). In total
∼3500 MS and MS/MS spectra were manually interpreted on the
basis of the mass, fragmentation pattern, and results of chemical
and enzymatic treatments; isomeric structures present in different
RP-HPLC fractions were defined on the basis of comparisons of the
aforementioned parameters. At least five MS/MS fragment ions were
used to aid definition of each of the structures.
HPLC Purification
of N-Glycans
Separation of PA-labeled
glycans was carried out on a Shimadzu HPLC system equipped with a
fluorescence detector (RF 10 AXL; 320/400 nm). In the case of RP-HPLC,
a Hypersil ODS column (C18; Agilent) was used with 100 mM ammonium
acetate, pH 4.0 (buffer A) and 30% (v/v) methanol (buffer B); a gradient
of increasing buffer B (1% per minute) was programmed. The column
was calibrated daily in terms of glucose units (g.u.) with a pyridylaminated
partial dextran hydrolysate. For 2D-HPLC, either normal-phase HPLC
(Tosoh TSKgel Amide-80) with an inverse gradient of acetonitrile in
10 mM ammonium formate, pH 7, or combined hydrophobic-interaction
anionic-exchange HPLC (HIAX, Dionex IonPac AS11) with an inverse gradient
of acetonitrile in 800 mM ammonium acetate, pH 3, was applied as previously
described.[4,27]
Structural Elucidation Using Exoglycosidases
and Chemical Treatment
In general, a 1 μL aliquot of
a HPLC fraction was mixed with
0.2 μL of exoglycosidase and 0.8 μL of 100 mM ammonium
acetate solution, pH 5.0 (except pH 6.5 in the case of the microbial
α1,2-fucosidase); after an overnight incubation at 37 °C,
0.5 μL aliquot of the mixture was analyzed by MALDI-TOF MS.
Exoglycosidases employed were: α-galactosidase from green coffee
beans (Sigma, 11 mU), recombinant β-galactosidase from Aspergillus niger [144 μU[28]], recombinant FDL β1,2-N-acetyl-glucosaminidase
[0.2 μU; specific for the nonreducing terminal GlcNAc on the
α1,3-arm[29]], jack bean α-mannosidase
(Sigma-Aldrich, 6.25 mU), and recombinant Xanthomonas manihotis α1,2/3- and α1,6-specific mannosidases [New England
Biolabs, 6–8 U[30]]. Also, digestions
were attempted with α-l-fucosidases from bovine kidney
(Sigma-Aldrich, 10 mU), Xanthomonas (α1,2-specific;
New England Biolabs, 4 mU), Corynebacterium (α1,2-specific;
Takara, 4 μU), or microbial (α1,2-specific E-FUCM; kind
gift of Megazyme). For the removal of α1,2/3-linked fucose or
methylfucose, glycan samples were dried in a Speed-Vac and then incubated
with 3 μL of 48% (w/v) hydrofluoric acid (HF) on ice for 24
h. The HF was allowed to evaporate overnight. Chemically or enzymatically
treated glycans were reanalyzed by MALDI-TOF MS and MS/MS without
further purification.
Analysis by LC–MS
A PA-labeled
N-glycan fraction
(5.5 g.u.) was analyzed by LC–MS/MS using a 10 cm × 150
μm I.D. column, prepared in-house, containing 5 μm porous
graphitized carbon (PGC) particles (Thermo Scientific, Waltham, MA).
Glycans were eluted using a linear gradient from 0 to 40% acetonitrile
in 10 mM ammonium bicarbonate over 40 min at a flow rate of 10 μL/min.
The eluted N-glycans were detected using an LTQ ion trap mass spectrometer
(Thermo Scientific) in negative-ion mode with an electrospray voltage
of 3.5 kV, capillary voltage of −33.0 V, and capillary temperature
of 300 °C. Air was used as a sheath gas and mass ranges were
defined dependent on the specific structure to be analyzed. Specific
ions were selected for MSn fragmentation using CID with
the collision energy set to 30%. The data were processed using the
Xcalibur software (version 2.0.7, Thermo Scientific) and the glycan
was identified from the MS/MS spectra by manual annotation.
Results
Preparation
and Initial Glycomic Analysis of Double Fucosyltransferase
Mutants
Due to the seeming infinite variety of fucosylated
N-glycans in Caenorhabditis elegans and the availability
of mutants with deletions in genes encoding the three core fucosyltransferases
(fut-1, fut-6, and fut-8; i.e., proximal and distal core α1,3- and proximal core α1,6-fucosyltransferases)
for which activities toward N-glycans have been defined, double mutants
(fut-1;fut-6, fut-1;fut-8, and fut-6;fut-8) were prepared and verified by PCR (Supplementary Figure S-1) to investigate the
putatively simplified N-glycomes. Indeed, initial mass spectrometric
screening suggested that there were maximally two fucose residues
on the N-glycans of these three strains.[24] Nevertheless, we anticipated that “off-line” LC–MALDI-TOF
MS would reveal a higher degree of variability in fucosylation as
compared with the fut-1;fut-6;fut-8 triple knockout
that features maximally one fucose residue on its N-glycans.The deeper investigation of the structural variability of the N-glycans
was based on MALDI-TOF MS of HPLC-separated fractions. Initially the
glycans were released by PNGase F, followed by PNGase A; as expected,
significant amounts of PNGase A-released material were found only
in the case of the fut-6;fut-8 mutant, which retains
the ability to core α1,3-fucosylate, a modification abolished
in the fut-1;fut-6 and fut-1;fut-8 strains. (Indeed the RP-HPLC chromatograms and MS spectra of the
PNGase A-released glycans of the latter two strains are identical
but of low intensity as compared with those after PNGase F; data not
shown.) Thus, only four N-glycan pools were analyzed in depth: the
PNGase F-released glycans of all three mutants and the PNGase A digest
(after PNGase F) of the fut-6;fut-8 mutant. RP-HPLC
of the pyridylaminated N-glycans was performed in all cases and showed
quite different elution profiles. All HPLC fractions were subject
to MS/MS backed up with enzymatic treatments or incubation with hydrofluoric
acid, a reagent known to remove various fucosidic and phosphodiester
modifications; as necessary, due to the complexity, “2D-HPLC”
with a second dimension on a HIAX column was performed in the case
of fut-1;fut-8 or NP-HPLC, followed by RP-HPLC for
the fut-1;fut-6 strain.
Analysis of the fut-6;fut-8 Mutant
The profile of the PNGase F-released
glycans for the fut-6;fut-8 mutant was very similar
to that of the recently published triple
mutant with a major peak of Man3GlcNAc2–PA
(7.2 g.u.) and a range of other glycans, including ones containing
maximally one fucose. Due to the early RP-HPLC elution position (4.2
to 5.2 g.u.; Figure A) and the complete absence of core-derived m/z 446 GlcNAc1Fuc1-PA fragment ions
(Figure B), the fucose
on these glycans was concluded to be solely on the bisecting galactose.
As these glycans are akin to those of the triple mutant,[20] they are not described here in greater detail;
relevant MS/MS and enzyme digestion data are summarized in Supplementary Table S-1.
Figure 1
RP-HPLC of pyridylamino-labeled
N-glycans of the fut-6;fut-8 double deletion strain.
N-glycans released by PNGase F ((A) F6F8F)
and PNGase A ((B) F6F8A; PNGase A digest following PNGase F) were
pyridylaminated and individual RP-HPLC fractions subject to MALDI-TOF
MS; characterized N-glycan structures are annotated on the chromatograms
using the nomenclature of the Consortium for Functional Glycomics
(circles, hexose; squares, N-acetylhexosamine; triangles,
fucose; Me, methyl; PC, phosphorylcholine); the most abundant in a
single fraction is shown uppermost. The asterisk indicates a fraction
with non-N-glycan contaminants and the inset in panel B shows which
core fucose residues are absent from this strain due to the deletion
of the relevant fucosyltransferases (shaded triangles). Oligomannosidic
and phosphorylcholine-modified glycans are also annotated but are
not further discussed in this study.
Figure 2
MALDI-TOF MS/MS analysis of isomeric forms of Hex4HexNAc2Fuc1 and Hex4HexNAc2Fuc2Me1 from the fut-1;fut-6, fut-1;fut-8, and fut-6;fut-8 deletion strains.
Five selected isomeric forms each of m/z 1297 and m/z 1457 glycans [M +
H]+ from PNGase F or A digests of the three double fucosyltransferase
mutants (F1F6, F1F8, and F6F8) occurring in RP-HPLC fractions of different
glucose units (g.u.) were subject to MALDI-TOF MS/MS in the positive
ion mode. Key fragments and the full structures are shown according
to the nomenclature of the Consortium for Functional Glycomics (Me,
methyl; PA, pyridylamino); the fragments surrounded by dashed squares
in panels C, G, and H are putative rearrangement products correlating
with the presence of distal (but not antennal) fucose modifications.
The 4.2 g.u. form of Hex4HexNAc2Fuc1 (panel B), previously analyzed from the fut-1;fut-6;fut-8 triple mutant, is found in all three double mutants. Loss of fucose
or hexose from the parent ions is indicated by −F or −H.
RP-HPLC of pyridylamino-labeled
N-glycans of the fut-6;fut-8 double deletion strain.
N-glycans released by PNGase F ((A) F6F8F)
and PNGase A ((B) F6F8A; PNGase A digest following PNGase F) were
pyridylaminated and individual RP-HPLC fractions subject to MALDI-TOF
MS; characterized N-glycan structures are annotated on the chromatograms
using the nomenclature of the Consortium for Functional Glycomics
(circles, hexose; squares, N-acetylhexosamine; triangles,
fucose; Me, methyl; PC, phosphorylcholine); the most abundant in a
single fraction is shown uppermost. The asterisk indicates a fraction
with non-N-glycan contaminants and the inset in panel B shows which
core fucose residues are absent from this strain due to the deletion
of the relevant fucosyltransferases (shaded triangles). Oligomannosidic
and phosphorylcholine-modified glycans are also annotated but are
not further discussed in this study.MALDI-TOF MS/MS analysis of isomeric forms of Hex4HexNAc2Fuc1 and Hex4HexNAc2Fuc2Me1 from the fut-1;fut-6, fut-1;fut-8, and fut-6;fut-8 deletion strains.
Five selected isomeric forms each of m/z 1297 and m/z 1457 glycans [M +
H]+ from PNGase F or A digests of the three double fucosyltransferase
mutants (F1F6, F1F8, and F6F8) occurring in RP-HPLC fractions of different
glucose units (g.u.) were subject to MALDI-TOF MS/MS in the positive
ion mode. Key fragments and the full structures are shown according
to the nomenclature of the Consortium for Functional Glycomics (Me,
methyl; PA, pyridylamino); the fragments surrounded by dashed squares
in panels C, G, and H are putative rearrangement products correlating
with the presence of distal (but not antennal) fucose modifications.
The 4.2 g.u. form of Hex4HexNAc2Fuc1 (panel B), previously analyzed from the fut-1;fut-6;fut-8 triple mutant, is found in all three double mutants. Loss of fucose
or hexose from the parent ions is indicated by −F or −H.In contrast, the PNGase A pool
of this mutant was dominated by
glycans of even earlier elution (2–4 g.u.; Figure B) for which typical m/z 446 core fucose fragment ions were
observed; however, the ratio of the intensity of the m/z 300 and 446 (Fuc0–1GlcNAc-PA)
fragment ions of approximately 1:1 correlates with core α1,3-fucosylation,
as opposed to the intensity ratio of about 1:9 observed in case of
the presence of core α1,6-fucose (Figure A,F and Supplementary Figure S-2B as compared with Figure D,I; see also refs (31) and (32)). In addition to the reduced
RP-HPLC retention, their sensitivity toward hydrofluoric acid and
their occurrence solely in the PNGase A pool led to the conclusion
that these glycans were core α1,3-fucosylated.It is noteworthy
that, other than the nonfucosylated pauci- and
oligomannosidic structures, even some of the simplest glycans (e.g.,
if considering all mutants, ten forms of Hex3HexNAc2Fuc1-PA; m/z 1135)
showed a multiplicity of isomeric structures (as judged by their retention
time in terms of glucose units), which could be distinguished by enzymatic
and chemical treatment and MS/MS fragmentation pattern. For example,
in addition to the PNGase F-releasable m/z 1135 isomer present also in the triple mutant (4.8 g.u.),
two PNGase A-releasable forms were found in the fut-6;fut-8 strain, which could not be distinguished on the basis of MS/MS.
The earliest eluting form (2.8 g.u.) could be digested down to Man1GlcNAc2Fuc1-PA by sequential treatment
with β-galactosidase and α1,2/3-mannosidase (Supplementary Figure S-3A–C), whereas
the same product for the 4.9 g.u. glycan was attained by use of two
specific mannosidases (Supplementary Figure S-3D–F). Thus, these two glycans were concluded to be core α1,3-fucosylated
forms of a bisected Hex3HexNAc2 (Gal1Man2GlcNAc2) and a standard Man3GlcNAc2 respectively, whereby the latter has the same
retention properties as a glycan from Pristionchus analyzed on the same column.[32] The predominant
glycan within the PNGase A pool (Hex4HexNAc2Fuc1; m/z 1297) was
analyzed by a similar procedure; this structure was α-mannosidase-resistant
prior to removal of the bisecting galactose and is concluded to be
an α1,3-fucosylated form of the Hex4HexNAc2 glycan previously found in the triple mutant (Figure A–E).
Figure 3
Digests of PNGase A-released glycans from
the fut-6;fut-8 mutant. (A–E) The 2.6 g.u.
RP-HPLC fraction, which contains
primarily two jack bean α-mannosidase-resistant N-glycan structures
((B) Hex4HexNAc2Fuc1–2-PA, m/z 1297 (for MS/MS see Figure A) and 1443), was incubated
sequentially with Aspergillus β-galactosidase
(C), α1,2/3-mannosidase (D), and α1,6-mannosidase (E),
resulting in a final product of m/z 811; digestion of the m/z 1443
glycan is blocked by the α1,2-fucose residue. The trace m/z 1135 structure (A) is more abundant
in the neighboring fraction (2.8 g.u.; see Supplementary Figure S-3A–C). (F–J) The 3.8 g.u. fraction was
treated with either microbial α1,2-fucosidase (Megazyme), which
removed the unmethylated α1,2-fucose substitution of the bisecting
galactose (G) or sequentially with hydrofluoric acid (H), Aspergillus β-galactosidase (I), and α1,2/3-mannosidase
(J) resulting in a major product of m/z 665. (K–N) The early eluting (3.0 g.u.) isomer of m/z 1457 was first treated with hydrofluoric
acid yielding products of m/z 1151
and 1311 (L); while subsequent Aspergillus β-galactosidase
and α1,2/3-mannosidase treatments serially removed bisecting
galactose and lower arm mannose from the m/z 1151 glycan (M,N), the m/z 1311 glycan, resulting from incomplete release of the methylfucose,
is resistant to these enzymes. (O–R) The later eluting (4.1
g.u.) form of m/z 1457 has a contrasting
α-galactosidase sensitivity, despite similarity of the MS/MS
spectra (for that of the untreated 3.0 g.u. form, see Figure F). Asterisks indicate nonglycan
contaminants in the enzyme preparations.
Digests of PNGase A-released glycans from
the fut-6;fut-8 mutant. (A–E) The 2.6 g.u.
RP-HPLC fraction, which contains
primarily two jack bean α-mannosidase-resistant N-glycan structures
((B) Hex4HexNAc2Fuc1–2-PA, m/z 1297 (for MS/MS see Figure A) and 1443), was incubated
sequentially with Aspergillus β-galactosidase
(C), α1,2/3-mannosidase (D), and α1,6-mannosidase (E),
resulting in a final product of m/z 811; digestion of the m/z 1443
glycan is blocked by the α1,2-fucose residue. The trace m/z 1135 structure (A) is more abundant
in the neighboring fraction (2.8 g.u.; see Supplementary Figure S-3A–C). (F–J) The 3.8 g.u. fraction was
treated with either microbial α1,2-fucosidase (Megazyme), which
removed the unmethylated α1,2-fucose substitution of the bisecting
galactose (G) or sequentially with hydrofluoric acid (H), Aspergillus β-galactosidase (I), and α1,2/3-mannosidase
(J) resulting in a major product of m/z 665. (K–N) The early eluting (3.0 g.u.) isomer of m/z 1457 was first treated with hydrofluoric
acid yielding products of m/z 1151
and 1311 (L); while subsequent Aspergillus β-galactosidase
and α1,2/3-mannosidase treatments serially removed bisecting
galactose and lower arm mannose from the m/z 1151 glycan (M,N), the m/z 1311 glycan, resulting from incomplete release of the methylfucose,
is resistant to these enzymes. (O–R) The later eluting (4.1
g.u.) form of m/z 1457 has a contrasting
α-galactosidase sensitivity, despite similarity of the MS/MS
spectra (for that of the untreated 3.0 g.u. form, see Figure F). Asterisks indicate nonglycan
contaminants in the enzyme preparations.There were various α1,3-fucosylated glycans (Hex3–4HexNAc2Fuc2Me0–1; m/z 1281, 1295, and 1457) concluded
to
be also capped with a fucose or methylfucose on the bisecting galactose,
as they were both β-galactosidase- and α-mannosidase-resistant;
this block could be released by prior removal with either α1,2-fucosidase
(in the case of the nonmethylated version) or hydrofluoric acid (Figure F–J,K–N);
the latter treatment was ∼50% efficient for fucose or methylfucose
removal from the bisecting galactose, whereas the core α1,3-fucose
is nearly completely released. The underlying bisecting β1,4-galactose
and the α1,3-mannose residues could then be removed in series
to yield final digestion products of m/z 665 (Figure J) or m/z 827 (Figure N). A further class of N-glycans in the fut-6;fut-8 mutant carried also α-galactose as exemplified
by the Hex4HexNAc2Fuc2Me1 glycan (m/z 1457) eluting at 4.1
g.u., isomeric with the one at 3.0 g.u.; the sensitivity to α-galactosidase
(Figure O–R)
is reminiscent of the α- and β-galactose-modified m/z 1313 glycan in the pmk-1 strain.[20] Methylation was concluded to
be not only on the fucose capping the bisecting galactose but also
on hexose, as judged by the presence of m/z 177 and 339 fragment ions (Hex1–2Me1; see Supplementary Figure S-2B and Supplementary Table S-1) for some glycans of low abundance such as m/z 841, 1149, 1309, 1325, 1471, and 1485.
Analysis of the fut-1;fut-8 Mutant
RP-HPLC
of the fut-1;fut-8 mutant glycome resulted
in a similar number of fractions as for fut-6;fut-8, but the major 5.5 g.u. fraction occurred solely in this mutant
and was rather complex in terms of the variety of glycans present
(Figure A and Supplementary Figure S-4A); thus, to further
resolve these, a second chromatographic dimension on the basis of
size (HIAX) was performed on this fraction. Alternatively, aliquots
of the entire fut-1;fut-8 glycome or of the 5.5.
g.u. fraction alone were subject to hydrofluoric acid prior to RP-HPLC;
in general, there was a shift to earlier retention times accompanied
by loss of fucose or methyl fucose alone, of fucose and hexose together,
or of phosphorylcholine (Figure B and Supplementary Figure S-4). Compatible with the deletion of genes encoding both enzymes which
fucosylate the proximal GlcNAc, glycans with strong m/z 446 and 608 (Gal0–1Fuc1GlcNAc1–PA) MS/MS fragment ions were absent.
Nevertheless, extremely low intensities of such ions were observed
and can be proposed as minimal rearrangements of fucose or fucose
and hexose from the distal GlcNAc (Figure C,G,H and Supplementary Figures S-2C,D and S-5E), which are absent once the distal
modification is removed by hydrofluoric acid; this phenomenon does
not occur upon MS/MS of glycans with a sole fucose on the bisecting
galactose. While rearrangements of fucose residues have been reported
in other studies,[33] the potential here
for residual glycans fucosylated on the reducing terminus is negligible
due to different HPLC retention time for these glycans and deletion
of the relevant genes.
Figure 4
RP-HPLC chromatograms of PNGase F released N-glycans of
the fut-1;fut-8 double deletion strain before and
after hydrofluoric
acid treatment. The untreated fraction eluting at 5.5 g.u. (A) was
collected and further separated using a HIAX column, which resulted
in seven glycan containing fractions (labeled 1–7; see inset).
The most abundant glycan in a single fraction is shown uppermost,
other than for the 5.5 g.u. fraction, in which the order of abundance
is from left to right. The inset in panel A highlights which core
fucose residues are absent from this strain (shaded triangles). The
effect of hydrofluoric acid treatment is shown in panel B. For reasons
of space, the elution positions of the pauci- and oligomannosidic
glycans are annotated with HN2. Asterisks indicate fractions containing no N-glycans.
RP-HPLC chromatograms of PNGase F released N-glycans of
the fut-1;fut-8 double deletion strain before and
after hydrofluoric
acid treatment. The untreated fraction eluting at 5.5 g.u. (A) was
collected and further separated using a HIAX column, which resulted
in seven glycan containing fractions (labeled 1–7; see inset).
The most abundant glycan in a single fraction is shown uppermost,
other than for the 5.5 g.u. fraction, in which the order of abundance
is from left to right. The inset in panel A highlights which core
fucose residues are absent from this strain (shaded triangles). The
effect of hydrofluoric acid treatment is shown in panel B. For reasons
of space, the elution positions of the pauci- and oligomannosidic
glycans are annotated with HN2. Asterisks indicate fractions containing no N-glycans.The delayed retention caused by the distal fucosylation,
as compared
with proximal core α1,3-fucosylation in the fut-6;fut-8 mutant, is evident and is similar to that seen in studies on other
nematodes.[31,32] The Hex4HexNAc2Fuc1 glycan (m/z 1297; HIAX fraction 4 from the 5.5 g.u. RP-HPLC peak), which was
initially resistant to jack bean mannosidase and only partially β-galactosidase-sensitive,
could be completely sequenced down to Hex1HexNAc2–PA by serial digestion with hydrofluoric acid, β-galactosidase
and α1,2/3-mannosidase (Figure A–F). Thus, while the bisecting galactose prevents
α-mannosidase digestion, the distal modification appears to
have a negative impact on the accessibility of the bisecting residue
as compared with the full β-galactosidase sensitivity of the
1297 isomer from the fut-6;fut-8 mutant eluting at
2.6 g.u. (see Figure A–E). As for the fut-6;fut-8 mutant, the
bisecting galactose could also be modified by fucose or methylfucose,
as exemplified by glycans of m/z 1443 and 1457. Upon hydrofluoric acid treatment, the de-2-fucosylated
portions were then β-galactosidase-sensitive (Supplementary Figure S-5 and Figure G–I).
Figure 5
Enzymatic and chemical treatments of Hex4HexNAc2Fuc1Me0 glycans from the fut-1;fut-8 strain. The
2D-HPLC fraction (HIAX fraction 4 of the 5.5 g.u. RP-HPLC fraction; Figure A, MS/MS spectrum
of m/z 1297 is shown in Figure C) was treated sequentially
with (B,C) jack bean α-mannosidase and then Aspergillus β-galactosidase or with (D–F) hydrofluoric acid, followed
by Aspergillus β-galactosidase and finally
α1,2/3-mannosidase. For the two variants of m/z 1457 ((G) HIAX fraction 3 of the 5.5 g.u. RP-HPLC
fraction and (J) the 6.2 g.u. RP-HPLC fraction), a differential effect
of hydrofluoric acid was observed (pairs of products of m/z 989/1149 or 1151/1311, which are due to losses
of 146, 160, or 308 Da (H,L)); the effects of subsequent treatment
of the former with Aspergillus β-galactosidase
(I) or digestion of the latter solely with α-galactosidase (K)
also indicated their structural difference. The absence of the putative
initial rearrangement fragments of low intensities at m/z 608 or 446 for these glycans (for MS/MS see Figure G,H) only after hydrofluoric
acid treatment (insets in panels I and L) is consistent with a correlation
between the presence of these rearrangement ions and distal core fucosylation.
Note that the properties of the distal GalFuc modification contrast
in terms of β-galactosidase and hydrofluoric acid sensitivity
with the reducing-terminal Galβ1,4Fucα1,6 motif. (See
data on glycans from the fut-1;fut-6 strain.) Components
in the β-galactosidase preparation resulted in a shift to sodiated
adducts. Asterisks indicate nonglycan contaminants in the enzyme preparations.
Enzymatic and chemical treatments of Hex4HexNAc2Fuc1Me0 glycans from the fut-1;fut-8 strain. The
2D-HPLC fraction (HIAX fraction 4 of the 5.5 g.u. RP-HPLC fraction; Figure A, MS/MS spectrum
of m/z 1297 is shown in Figure C) was treated sequentially
with (B,C) jack bean α-mannosidase and then Aspergillus β-galactosidase or with (D–F) hydrofluoric acid, followed
by Aspergillus β-galactosidase and finally
α1,2/3-mannosidase. For the two variants of m/z 1457 ((G) HIAX fraction 3 of the 5.5 g.u. RP-HPLC
fraction and (J) the 6.2 g.u. RP-HPLC fraction), a differential effect
of hydrofluoric acid was observed (pairs of products of m/z 989/1149 or 1151/1311, which are due to losses
of 146, 160, or 308 Da (H,L)); the effects of subsequent treatment
of the former with Aspergillus β-galactosidase
(I) or digestion of the latter solely with α-galactosidase (K)
also indicated their structural difference. The absence of the putative
initial rearrangement fragments of low intensities at m/z 608 or 446 for these glycans (for MS/MS see Figure G,H) only after hydrofluoric
acid treatment (insets in panels I and L) is consistent with a correlation
between the presence of these rearrangement ions and distal core fucosylation.
Note that the properties of the distal GalFuc modification contrast
in terms of β-galactosidase and hydrofluoric acid sensitivity
with the reducing-terminal Galβ1,4Fucα1,6 motif. (See
data on glycans from the fut-1;fut-6 strain.) Components
in the β-galactosidase preparation resulted in a shift to sodiated
adducts. Asterisks indicate nonglycan contaminants in the enzyme preparations.In the case of m/z 1135, 1297,
1443, and 1457, two isomers with different fragmentation and putative
rearrangement fragments of low intensities at either m/z 608 or 446 (see Supplementary Table S-1) were observed. For those structures with traces
of m/z 608, serial losses of hexose
and fucose (resulting in fragments of m/z 1135/989, 1295/1149, 1281/1135, and 1309/1163) were observed for m/z 1297, 1457, 1443, and 1471, respectively
(Figure C,G and Supplementary Figures S-5E and S-2C); where low
intensity m/z 446 fragment ions
occurred, only loss of fucose from the parent ion was visible, as
shown by the fragments of m/z 1311
and 1339 in the case of the m/z 1457
and 1485 glycans (Figure H and Supplementary Figure S-2D), which, instead of carrying a hexose on the distal fucose, were
modified by α-galactose on the lower arm mannose. Furthermore,
these glycans lost either 308 (HexFuc) or 146 (Fuc) upon HF treatment
from the distal GlcNAc, as shown for the two m/z 1457 methylated glycans (Figure G–L), and lacked an “upper
arm” α1,6-mannose in accordance with the specificity
of FUT-6.[24] Whereas methyl groups were
found on mannose residues (e.g., on m/z 841, 1149, 1309, and 1471) in addition to the antennal fucose, the
distal (galactosyl)fucose was never methylated.
Analysis of
the fut-1;fut-6 Mutant
Of the three double
mutants, the chromatogram for the glycome of the fut-1;fut-6 mutant was the most complex with some 23 RP-HPLC glycan-containing
fractions (Figure ); therefore, 2D-HPLC (NP-HPLC followed by RP-HPLC) was also performed
to yield fractions with a reduced number of glycans (Supplementary Figure S-6). As the core α1,6-fucosylation
capacity was intact, a large percentage of the glycans had a relatively
late retention time (later than 6.5 g.u.), in keeping with previous
data on the RP-HPLC properties of core α1,6-fucosylated glycans.[32,34] In comparison with the rather discrete regions of the fut-6;fut-8 and fut-1;fut-8 chromatograms containing difucosylated
glycans, the elution positions for such oligosaccharides in the fut-1;fut-6 glycome ranged from 6.5 to >20 g.u. In addition,
late-eluting trifucosylated glycans (>11 g.u.) were also detected
in this mutant, which possessed m/z 754 or 768 MS/MS core fragment ions (Hex1HexNAc1Fuc2Me0–1-PA; Supplementary Figure S-2G,H,I,N,R,S), while the earlier difucosylated glycans
(6.5–11 g.u.) only had key core fragments of m/z 446 or 608 (Hex0–1HexNAc1Fuc1-PA; Figure D,E,I,J and Supplementary Figure S-2F,M,O). This suggested that, in addition to fucose directly
substituting the proximal core GlcNAc residues in α1,6 linkage,
there are two different positions (one core, on the Galβ1,4Fucα1,6,
and one peripheral, on the bisecting galactose) for an “extra”
fucose residue in this strain. Furthermore, some intermediate-eluting
glycans (8–13 g.u.) possessed m/z 770 fragments (Hex2HexNAc1Fuc1-PA; Supplementary Figure 2J,P,Q,T) as previously
defined in the hex-2;hex-3 mutant strain as representing
two β1,4 galactoses serially linked to the α1,6 core fucose.[18] A final core variant is represented by glycans
with m/z 460 fragments (HexNAc1Fuc1Me1-PA; Supplementary Figure S-2A,E); this represents methylation of the core α1,6-fucose,
which contrasts with methylated core α1,3-fucose found in Pristionchus.[32] Additionally,
early eluting N-glycans lacking core fucosylation were also observed
in this strain as in the triple and the two other mutants; these are
concluded to be bisected with and without fucose on the bisecting
galactose.
Figure 6
RP-HPLC chromatogram of PNGase F released N-glycans of the fut-1;fut-6 double knockout. PA-labeled N-glycans were fractionated
by an RP-HPLC column; fractions were collected and subject to MALDI
MS, MS/MS, and enzymatic and chemical treatments. Characterized structures
from both RP-HPLC fractions and 2D-HPLC fractions (see Supplementary Figure S-6) are summarized and
annotated on the RP-HPLC chromatogram. The most abundant glycans in
a single fraction are shown either uppermost or on the left. The inset
indicates which core fucose residues are absent from this strain (shaded
triangles). For reasons of space, the elution positions of the pauci-
and oligomannosidic glycans are indicated by HN2.
RP-HPLC chromatogram of PNGase F released N-glycans of the fut-1;fut-6 double knockout. PA-labeled N-glycans were fractionated
by an RP-HPLC column; fractions were collected and subject to MALDI
MS, MS/MS, and enzymatic and chemical treatments. Characterized structures
from both RP-HPLC fractions and 2D-HPLC fractions (see Supplementary Figure S-6) are summarized and
annotated on the RP-HPLC chromatogram. The most abundant glycans in
a single fraction are shown either uppermost or on the left. The inset
indicates which core fucose residues are absent from this strain (shaded
triangles). For reasons of space, the elution positions of the pauci-
and oligomannosidic glycans are indicated by HN2.One of the simplest monofucosylated compositions in this
strain
(Hex4HexNAc2Fuc1; m/z 1297) is represented by eight isomeric structures
(see Supplementary Table S-1). Three of
these possessed similar MS/MS spectra with an m/z 608 fragment compatible with a proximal GalFuc epitope
(9.2, 14, and 15 g.u.). The latter (see Figure E) is a simple galactosylated version of
the major fucosylated paucimannosidic MMF6 structure as
also analyzed from Pristionchus.[32] The 14 g.u. glycan was, however, shown to carry a peripheral
α-galactose but lacked the α1,6-mannose residue, as after
removal of the α-galactose residue the glycan was α1,2/3-mannosidase-sensitive
(Figure A–C).
An earlier-eluting isomeric structure (9.2 g.u.) was, on the contrary,
losing two hexose residues upon β-galactosidase treatment (Figure E); the MS/MS data
suggested that this is due to the loss of a GalFuc epitope and a bisecting
galactose. In the same fraction, an m/z 1457 glycan lost only one galactose residue upon β-galactosidase
treatment but was also sensitive to hydrofluoric acid; this indicated
that the difference between the coeluting m/z 1297 and 1457 glycans was a methylfucose residue attached
to the bisecting galactose of the latter (Figure D–F). There was also a second m/z 1457 isobaric structure (8.4 g.u.)
that lacked the m/z 608 fragment
(see Figure I) but
was sensitive to bovine α-fucosidase (conversion of the m/z 446 core fragment to one at m/z 300), α-galactosidase, and hydrofluoric
acid (Figure G–J).
Thus, this isomer was concluded to be a core α1,6-fucosylated
glycan with an α-galactose and a methylfucosylated bisecting
β-galactose. Further examples of isomeric glycans varying in
having either a bisecting β-galactose on a Man3GlcNAc2 structure or an antennal α-galactose are two glycans
of m/z 1459 (compare different galactosidase
sensitivities in Figure K–M with N–P). The linkage of the galactose to mannose
observed in various glycans was investigated by LC–MSn of a non-core-fucosylated α-galactosidase-sensitive m/z 1311 structure: An α1,4-linkage
of galactose to the α1,3-linked mannose can be proposed based
on the presence of fragment ions at m/z 263 (0,2A2-H2O; for the relevant
LC–MS3 data, see Figure ).
Figure 7
Sequential treatments of N-glycans from the fut-1;fut-6 strain. 2D-HPLC (normal phase followed by reversed
phase) fractions
containing isomeric N-glycans (Hex4–5HexNAc2Fuc1–2Me0–1-PA) were sequentially
treated with α-galactosidase and α1,2/3-mannosidase (A–C)
or independently treated with Aspergillus β-galactosidase
and HF (D–F), bovine α-fucosidase, α-galactosidase,
or HF (G–J), or with α-galactosidase or Aspergillus β-galactosidase (K–P). All glycans were fragmented
and key core fragments are highlighted in red. The relevant MS/MS
spectra of the untreated m/z 1457
glycans (panels D and G) are shown, respectively, in Figure J,I, whereas the seemingly
identical MS/MS spectra of the m/z 1459 glycans are provided as insets (K and N). Note that the reducing
terminal Galβ1,4Fucα1,6 motif is β-galactosidase-sensitive
but hydrofluoric-acid-resistant; this contrasts with the properties
of the distal GalFuc motif found on glycans of the fut-1;fut-8 mutant (see Figure ; m/z 1297 and 1457).
Figure 8
LC–MSn spectra of an N-glycan with an
α-galactosylated
mannose (Gal-Man). (A,B) MS/MS fragmentation spectra of Hex4HexNAc2Fuc1Me1-PA (5.5 g.u.) in,
respectively, the doubly and single charged state: m/z 654.53 [M-2H]2– and m/z 1309.51 [M-H]−. Dominant
ions are typical cross-ring and glycosidic cleavages for N-glycans
(2,4A4, 0,2A4, 0,2A4-H2O, B4, and C3 ions). The fragment ions
at m/z 341 (C2β ions in A) and m/z 423 (0,2A3/Z3β ions in B) suggest two hexoses
in series. The absence of fragmentation ions at m/z 323 (Hex2-H2O) or 467 (Hex3-H2O) suggests a lack of α1,6-Man in this
structure as found in the previous study.[20] Thus, the terminal Hex is proposed to be linked to an α1,3Man,
while the Y4α ions indicate that the terminal methylated
Fuc is linked to bisecting β1,4Gal. (C) In the case of the MS[3] spectra of m/z 867.28 (2,4A4 ions) derived from the m/z 1309.51 precursor, the presence of
fragmentation ions at m/z 263 (0,2A2-H2O) suggests that the terminal
hexose is C4-linked to the α-mannose. (D) The RP-HPLC fraction
containing Hex4HexNAc2Fuc1Me1-PA (5.5 g.u.) was treated with green coffee beans α-galactosidase,
resulting in the loss of the putatively α1,4Gal residue (mass
shift from m/z 1311.6 to m/z 1149.5).
Sequential treatments of N-glycans from the fut-1;fut-6 strain. 2D-HPLC (normal phase followed by reversed
phase) fractions
containing isomeric N-glycans (Hex4–5HexNAc2Fuc1–2Me0–1-PA) were sequentially
treated with α-galactosidase and α1,2/3-mannosidase (A–C)
or independently treated with Aspergillus β-galactosidase
and HF (D–F), bovine α-fucosidase, α-galactosidase,
or HF (G–J), or with α-galactosidase or Aspergillus β-galactosidase (K–P). All glycans were fragmented
and key core fragments are highlighted in red. The relevant MS/MS
spectra of the untreated m/z 1457
glycans (panels D and G) are shown, respectively, in Figure J,I, whereas the seemingly
identical MS/MS spectra of the m/z 1459 glycans are provided as insets (K and N). Note that the reducing
terminal Galβ1,4Fucα1,6 motif is β-galactosidase-sensitive
but hydrofluoric-acid-resistant; this contrasts with the properties
of the distal GalFuc motif found on glycans of the fut-1;fut-8 mutant (see Figure ; m/z 1297 and 1457).LC–MSn spectra of an N-glycan with an
α-galactosylated
mannose (Gal-Man). (A,B) MS/MS fragmentation spectra of Hex4HexNAc2Fuc1Me1-PA (5.5 g.u.) in,
respectively, the doubly and single charged state: m/z 654.53 [M-2H]2– and m/z 1309.51 [M-H]−. Dominant
ions are typical cross-ring and glycosidic cleavages for N-glycans
(2,4A4, 0,2A4, 0,2A4-H2O, B4, and C3 ions). The fragment ions
at m/z 341 (C2β ions in A) and m/z 423 (0,2A3/Z3β ions in B) suggest two hexoses
in series. The absence of fragmentation ions at m/z 323 (Hex2-H2O) or 467 (Hex3-H2O) suggests a lack of α1,6-Man in this
structure as found in the previous study.[20] Thus, the terminal Hex is proposed to be linked to an α1,3Man,
while the Y4α ions indicate that the terminal methylated
Fuc is linked to bisecting β1,4Gal. (C) In the case of the MS[3] spectra of m/z 867.28 (2,4A4 ions) derived from the m/z 1309.51 precursor, the presence of
fragmentation ions at m/z 263 (0,2A2-H2O) suggests that the terminal
hexose is C4-linked to the α-mannose. (D) The RP-HPLC fraction
containing Hex4HexNAc2Fuc1Me1-PA (5.5 g.u.) was treated with green coffee beans α-galactosidase,
resulting in the loss of the putatively α1,4Gal residue (mass
shift from m/z 1311.6 to m/z 1149.5).Still more structurally complex than the various Hex4–5HexNAc2Fuc1 and Hex4HexNAc2Fuc2Me1 isomers was the m/z 1619 glycan (10.2 g.u.), which contains
all of the various
elements (proximal GalFuc, α-galactose, and methylfucosylated
bisecting β-galactose). Although analysis of this glycan (one
of the major fucosylated ones in this strain) was complicated by the
presence of five other minor components, it was inferred that it could
be digested down to m/z 811 (Hex1HexNAc2Fuc1-PA; Supplementary Figure S-7) by serial digestion with hydrofluoric
acid, α-mannosidase, β-galactosidase, α-galactosidase,
and α1,2/3-mannosidase. The loss of β-galactose on the
core α1,6-fucose residue was apparent due to the loss of the m/z 608 MS/MS fragment upon β-galactosidase
digestion and the appearance of one at m/z 446 (see MS/MS of m/z 1135, right-hand panels of Supplementary Figure S-7).Related glycans, either lacking a methyl group
(m/z 1605), containing an extra
mannose (m/z 1781), lacking a methyl
group and possessing
a third fucose (m/z 1751), or having
a methylfucose on the proximal GalFuc (m/z 1779), were also subject to various treatments to confirm
their structures. Thereby, the α-mannosidase resistance and
α-galactosidase sensitivity of the m/z 1605 and 1781 glycans was associated with no change in
the presence of the m/z 608 fragment
(Figure A–C).
On the other hand, the m/z 754 fragment
of the m/z 1751 glycan was lost
upon bovine fucosidase treatment, indicating that one of two fucose
residues removed was linked to the proximal core GalFuc epitope; partial
hydrolysis of either of the terminal α1,2-fucose residues with
hydrofluoric acid resulted in two isomeric intermediate products,
one of which still retained the m/z 754 fragment (Figure D–F). In the case of the Hex5HexNAc2Fuc3Me2 glycan (m/z 1779), methylation of two of the fucose residues meant
that only a partial removal with hydrofluoric acid resulted in mass
shifts to m/z 1459 and 1619; a subsequent
treatment with β-galactosidase resulted in the appearance of
a product of m/z 1135 in which both
the core elongation and bisecting Fucα1,2Gal motifs had been
removed (Figure G–I).
Thus, the m/z 1751 and 1779 glycans
are representative of those with the highest degree of fucosylation
in the three double fucosyltransferase mutants with methylation of
two of the three fucose residues being possible; even larger, but
only difucosylated glycans (m/z 1929
and 1943; see Supplementary Table S-1),
contained putatively four galactose residues. In this strain, but
not in the other two, phosphorylcholine-modified N-glycans were found
that were also core fucosylated (see also the Supplementary Table S-1).
Figure 9
Structural analysis of core modifications
of N-glycans isolated
from the fut-1;fut-6 strain. N-glycans (Hex4–6HexNAc2Fuc2–3Me0–2-PA) separated by either RP-HPLC or 2D-HPLC were subject to various
treatments. A 9.4 g.u. RP fraction containing three major glycans
(m/z 1457, 1605, and 1781) was incubated
with either jack bean α-mannosidase or α-galactosidase
(A–C). Two 2D-HPLC fractions containing trifucosylated structures
(m/z 1751 and 1779) were treated
either with hydrofluoric acid and bovine α-fucosidase (D–F)
or sequentially with hydrofluoric acid and Aspergillus β-galactosidase (G–I). Key core MS/MS fragments of
relevant N-glycans are shown in the right panels.
Structural analysis of core modifications
of N-glycans isolated
from the fut-1;fut-6 strain. N-glycans (Hex4–6HexNAc2Fuc2–3Me0–2-PA) separated by either RP-HPLC or 2D-HPLC were subject to various
treatments. A 9.4 g.u. RP fraction containing three major glycans
(m/z 1457, 1605, and 1781) was incubated
with either jack bean α-mannosidase or α-galactosidase
(A–C). Two 2D-HPLC fractions containing trifucosylated structures
(m/z 1751 and 1779) were treated
either with hydrofluoric acid and bovine α-fucosidase (D–F)
or sequentially with hydrofluoric acid and Aspergillus β-galactosidase (G–I). Key core MS/MS fragments of
relevant N-glycans are shown in the right panels.
Discussion
Glycomics of Mutant Nematodes
Employing
off-line LC–MALDI-TOF
MS in combination with MS/MS and various treatments of glycans, we
reveal a high degree of isomeric variation in the glycomes of three
double-core fucosyltransferase mutant C. elegans strains.
The greatest spread of glycan structures, in terms of number, of mass,
and of RP-HPLC glucose units, is in the fut-1;fut-6 mutant (Supplementary Figure S-8). Indeed,
the deletion of these two α1,3-fucosyltransferase genes seemingly
pushes the glycome toward α1,2-fucosylation of the bisecting
galactose and core Galβ1,4Fuc motifs. On the other hand, the
PNGase F-released pool from the fut-6;fut-8 mutant
resembles, perhaps not surprisingly, that of the fut-1;fut-6;fut-8 triple mutant, considering the lack of core α1,3-fucosylated
glycans in both cases.The maximum complexity of the fucosylated
N-glycans isolated from the double-knockout strains is represented
by glycans of m/z 1619 (Hex5HexNAc2Fuc2Me1) in the case
of both the fut-1;fut-8 and fut-6;fut-8 strains and m/z 1927, 1941, and
1943 (Hex6–7HexNAc2Fuc2–3Me1–2) in the fut-1;fut-6 strain
(Figure A). Only
the latter mutant, therefore, contains glycans with up to three fucose
residues, as opposed to four in the wild-type N2 strain.[19] The maximum number of hexose residues, other
than in oligomannosidic glycans, is also higher when the degree of
fucosylation increases, which is related to galactose capping of fucose
in addition to galactose capping of mannose. The same type of β1
4-digalactosylation of the core α1,6-fucose as found in fut-1;fut-6 was also observed in the hex-2;hex-3 strain in which proximal core α1,3-fucosylation is also absent
due to nonreducing terminal GlcNAc on the α1,3-arm being a “NOGO”
signal for the relevant FUT-1 enzyme.[18] In addition to the Galα1,2Fuc modification of the distal core
GlcNAc previously proposed on the basis of GC–MS and enzymatic
digestion[18] and the bisecting β1,4-galactose
defined also by NMR,[20] a further form of
galactosylation can also now, as judged by negative ion mode LC–MS[3] data, be proposed to be a Galα1,4Man motif.
Figure 10
Elution
properties of isobaric glycans on RP-HPLC. The most complicated
fucosylated N-glycan structures found in each double mutant are illustrated
in panel A. Characterized isobaric glycan structures are listed according
to their elution properties on the RP-HPLC (C18) column in terms of
glucose units (B–E). Stepped dashed lines between panels D
and E indicate the shifts caused by methylation of the α1,2-fucose
on the bisecting galactose residue. (F) Summary of the linkages of C. elegans N-glycans with an indication of the glycosyltransferases
(FUT-1, -6, -8 and GALT-1) with proven biosynthetic roles. The asterisked
α1,6-mannose is absent from glycans modified by FUT-6, whereas
the α1,4-linked galactose on the α1,3-mannose is defined
in this study for the first time; for the two α1,2-fucose, the
methyl groups and the other galactose residues, the relevant enzymes
are unknown.
Elution
properties of isobaric glycans on RP-HPLC. The most complicated
fucosylated N-glycan structures found in each double mutant are illustrated
in panel A. Characterized isobaric glycan structures are listed according
to their elution properties on the RP-HPLC (C18) column in terms of
glucose units (B–E). Stepped dashed lines between panels D
and E indicate the shifts caused by methylation of the α1,2-fucose
on the bisecting galactose residue. (F) Summary of the linkages of C. elegans N-glycans with an indication of the glycosyltransferases
(FUT-1, -6, -8 and GALT-1) with proven biosynthetic roles. The asterisked
α1,6-mannose is absent from glycans modified by FUT-6, whereas
the α1,4-linked galactose on the α1,3-mannose is defined
in this study for the first time; for the two α1,2-fucose, the
methyl groups and the other galactose residues, the relevant enzymes
are unknown.The experimental workflow
and data interpretation presented here
are indeed the result of what we have learned from glycomic analyses
on the aforementioned triple mutant,[20] which
lacks all complex core modifications and so is biased toward bisecting
modifications, and on a double hexosaminidase deletion strain,[18] which lacks core α1,3-fucosylation and
bisecting galactose but displays increased modifications of the distal
core GlcNAc and core α1,6-fucose. Some of these motifs have
been found in other nematodes: specifically, the galactosylated core
α1,6-fucose and galactosylated distal α1,3-fucose have
both been observed in Ascaris, Haemonchus, Pristionchus, and Oesophagostomum.[18,31,32] Methylation
of core α1,3-fucose, rather than of the α1,6-fucose as
in this study, is a low-abundance feature of Pristionchus.[32] The bisecting galactose and α1,2-fucose
or β1,4-galactose capping of Galβ1,4Fuc is yet to be found
in any nematode other than C. elegans. On the other
hand, phosphorylcholine is a rather common modification of nematode
glycans and is, as in Pristionchus and Trichuris,[32,35] often associated with core α1,6-fucose;
this applies to the mutants studied here in which Hex3HexNAc3–4PC1–2 structures were detected
in all three strains with fucosylated forms thereof found only in
the fut-1;fut-6 mutant (see Supplementary Table S-1). A minor phosphorylcholine-modified glycan even
carried a core Galβ1,4Fuc modification (Supplementary Figure S-2K).
Elution and Digestion Characteristics
Resulting from Nematode
N-Glycan Motifs
The use of RP-HPLC as part of the glycomic
strategy is valuable in separating isomeric and isobaric structures.
The differential effect of core α1,3- and α1,6-fucosylation
is well known to cause, respectively, early and late elution.[34] Also, phosphorylcholine modifications affect
the elution of glycans in a column-specific manner.[32] In the present study, we can extend the range of observations
regarding retention on a standard C18 chromatography material. Further
effects are the linkages of the mannose residues, presence of α-galactose
or bisecting β-galactose, distal α1,3-fucosylation, methylation,
and capping of the core α1,6-fucose. Thus, considering the range
of isomeric structures found in one or more of the three double-mutant
strains, we can determine the relative elution properties of, for
example, six forms of Hex2HexNAc2Fuc1-PA, ten forms of Hex3HexNAc2Fuc1-PA, and seven forms each of Hex4HexNAc2Fuc2-PA and Hex4HexNAc2Fuc2Me1-PA (Figure B–E). Comparing the 973 isomers, (i) the forms with the α1,3-mannose
elute earlier than those with the α1,6-mannose, (ii) core α1,3-fucosylation
results in early elution, (iii) distal core α1,3-fucosylation
results in an intermediate retention, (iv) proximal α1,6-fucose
shifts to high retention, and (v) capping of the proximal α1,6-fucose
with one galactose causes a large increase in retention (Figure B). Analogous effects
are observed in the case of the 1135 isomers, for which additionally
earlier retention results from the presence of bisecting galactosylation;
later retention is caused by α1,4-galactosylation of either
the α1,3-mannose or by β-galactosylation of α1,6-fucose,
whereas galactosylation of distal α1,3-fucose results in minimal
effects (Figure C). Double fucosylation (i.e., one core fucose and one antennal fucose)
results in generally earlier elution, which is counteracted by methylation
of fucose on the bisecting galactose (Figure D,E). Interestingly, the presence of an m/z 768, rather than an m/z 754, fragment ion is associated with decreased
retention time of glycans with the former as compared with the latter
(Supplementary Figure S-8), despite methylation
generally resulting in delayed elution.One can assume that
the overall conformation of the glycan affects its interaction with
reversed-phase resins, but also steric effects impact the susceptibility
to glycosidases. (For possible conformations of selected glycans,
see Supplementary Figure S-9.) For instance,
the reduced β-galactosidase sensitivity of the bisecting galactose
in the case of distally modified glycans (Supplementary Figure S-9B,C) can thereby be explained by the close proximity
of the fucose on the distal GlcNAc to the bisecting galactose, whereas
modifications of the proximal GlcNAc (E) are more distant and have
no inhibitory effect. Interestingly, bovine α-fucosidase will
remove all terminal unmethylated fucose residues, other than the proximal
core α1,3-fucose, from C. elegans N-glycans.
Only if the glycan has a trimannosyl core is the fucose attached to
the bisecting galactose resistant to this enzyme (G), whereas glycans
without the α1,6-mannose (but having an α-galactose on
the α1,3-mannose and even an extended proximal core modification)
are still sensitive (H,I), which may be due to the crowded conformation
of the former. The ability by α1,2-fucosidase to remove either
α1,2-fucose residues (i.e., on the bisecting galactose or the
proximal GalFuc motifs) depends on the source of the enzyme with the
microbial one being even more effective than chemical treatment (Figure G,H).
Biosynthetic
and Biological Repercussions of Altered Fucosylation
in Nematodes
The glycan structures we find are products of
maturation pathways in the Golgi apparatus of the worm, and we can
thereby begin to make inferences about “GO” and “NOGO”
biosynthetic signals, which differ from those known from mammalian
cells;[36] for instance, trimming down to
trimannosyl core allows α-galactosylation of mannose and the
absence of the α1,6-mannose allows distal core fucosylation
to take place. However, the biosynthetic basis for only four of the
core modifications is known (Figure F) and the glycomic repercussions of deletions of the
currently identified relevant fut-1, fut-6, fut-8, and galt-1 genes are
clear from this and previous studies. In the triple knockout four
N-glycan fucosylation events were directly or indirectly abolished,
enabling us to verify the bisecting modification;[20] although knocking out of the core fucosyltransferases does
not affect the bisecting modification directly, it increased the chances
of seeing such glycans due to a higher amount of the fewer individual
structures. Of course, the absence of various enzymes in the Golgi
apparatus can obviously lead to “unnatural” glycoforms
that are absent or minimally present in the wild-type, either due
to direct substrate-dependent effects or theoretically also to indirect
ones due to alteration of the targeting of proteins in the Golgi,
if absent glycosyltransferases would be normally associated with others
in complexes.The abolition of some fucosylation events affects
the presence of various motifs recognized by nematotoxic lectins.
Previously, a deletion in the fut-1 gene was observed
to induce resistance to CCL2, a lectin from the ink cap mushroom;
interestingly, the fut-1;fut-6 double mutant was
completely resistant to the lectin.[26] On
the other hand, various single fut mutants as well
as the fut-1;fut-8 double mutant are still as fully
sensitive against the Aleuria aurantia lectin as
the wild type (M. Künzler, personal communication); however,
as this lectin binds a range of fucosylated glycoconjugates,[37] redundancy in terms of its targets is possible.
Additionally, deletion of core fucosyltransferases affects galactosylation
(e.g., the Galβ1,4Fucα1,6 motif) and so the fut-8 single mutant is also resistant to the mushroom galectin CGL2,[21] which is one of four lectins also toxic to Haemonchus contortus.[38] With
the assignment of the actual glycan structures in various fucosylation
mutants, in comparison with parasitic worms, we can begin to understand
why certain patterns of resistance and sensitivity toward lectins
are observed and so aid the development of potential new therapies
against helminth parasites, which share with C. elegans the same range of modifications of the N-glycan core. Furthermore,
the present data are a basis for a final definition of the estimated
more than 100 N-glycan structures in the wild-type strain of the model
nematode.
Authors: Shi Yan; Silvia Bleuler-Martinez; David Fernando Plaza; Markus Künzler; Markus Aebi; Anja Joachim; Ebrahim Razzazi-Fazeli; Verena Jantsch; Rudolf Geyer; Iain B H Wilson; Katharina Paschinger Journal: J Biol Chem Date: 2012-06-25 Impact factor: 5.157
Authors: Katharina Paschinger; Alba Hykollari; Ebrahim Razzazi-Fazeli; Pamela Greenwell; David Leitsch; Julia Walochnik; Iain B H Wilson Journal: Glycobiology Date: 2011-10-07 Impact factor: 4.313
Authors: Mario Schubert; Silvia Bleuler-Martinez; Alex Butschi; Martin A Wälti; Pascal Egloff; Katrin Stutz; Shi Yan; Mayeul Collot; Jean-Maurice Mallet; Iain B H Wilson; Michael O Hengartner; Markus Aebi; Frédéric H-T Allain; Markus Künzler Journal: PLoS Pathog Date: 2012-05-17 Impact factor: 6.823
Authors: Alex Butschi; Alexander Titz; Martin A Wälti; Vincent Olieric; Katharina Paschinger; Katharina Nöbauer; Xiaoqiang Guo; Peter H Seeberger; Iain B H Wilson; Markus Aebi; Michael O Hengartner; Markus Künzler Journal: PLoS Pathog Date: 2010-01-08 Impact factor: 6.823
Authors: Alba Hykollari; Crina I A Balog; Dubravko Rendić; Thomas Braulke; Iain B H Wilson; Katharina Paschinger Journal: J Proteome Res Date: 2013-01-27 Impact factor: 4.466
Authors: Ewa Jankowska; Lisa M Parsons; Xuezheng Song; Dave F Smith; Richard D Cummings; John F Cipollo Journal: Glycobiology Date: 2018-04-01 Impact factor: 4.313
Authors: Rhiannon Stanton; Alba Hykollari; Barbara Eckmair; Daniel Malzl; Martin Dragosits; Dieter Palmberger; Ping Wang; Iain B H Wilson; Katharina Paschinger Journal: Biochim Biophys Acta Gen Subj Date: 2017-01-08 Impact factor: 4.117
Authors: Alba Hykollari; Daniel Malzl; Barbara Eckmair; Jorick Vanbeselaere; Patrick Scheidl; Chunsheng Jin; Niclas G Karlsson; Iain B H Wilson; Katharina Paschinger Journal: Mol Cell Proteomics Date: 2018-08-13 Impact factor: 7.381